Symbols / WW Stock $9.64 -3.50% WW International, Inc.

Healthcare • Medical Care Facilities • United States • NGM
WW (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Care Facilities
CEO —
Exch · Country NGM · United States
Market Cap 96.39M
Enterprise Value 400.01M
Income 1.06B
Sales 710.64M
FCF (ttm) 23.84M
Book/sh 31.83
Cash/sh 16.03
Employees 3,500
Insider 10d —
IPO Jun 27, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E 1.54
Forward P/E -72.30
PEG —
P/S 0.14
P/B 0.30
P/C —
EV/EBITDA 2.69
EV/Sales 0.56
Quick Ratio 1.40
Current Ratio 1.69
Debt/Eq 147.33
LT Debt/Eq —
EPS (ttm) 6.28
EPS next Y -0.13
EPS Growth —
Revenue Growth -11.70%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-07
Earnings (prior) 2026-05-07
ROA 6.74%
ROE —
ROIC —
Gross Margin 71.72%
Oper. Margin -5.38%
Profit Margin 148.60%
Shs Outstand 10.00M
Shs Float 7.79M
Insider Own 0.17%
Instit Own 67.74%
Short Float —
Short Ratio 4.23
Short Interest 1.37M
52W High 46.95
vs 52W High -79.47%
52W Low 8.37
vs 52W Low 15.24%
Beta —
Impl. Vol. 6.25%
Rel Volume 0.56
Avg Volume 337.67K
Volume 188.45K
Target (mean) $28.33
Tgt Median $30.00
Tgt Low $20.00
Tgt High $35.00
# Analysts 3
Recom Buy
Prev Close $9.99
Price $9.64
Change -3.50%
About

WW International, Inc. provides weight management products and services in the United States, Germany, Canada, and internationally. It offers various nutritional, activity, behavioral, and lifestyle tools and approaches for individual weight goals, as well as for people taking GLP-1 medications or living with diabetes, as well as offers guidance and medication access for women reaching perimenopause and menopause. The company also provides Core, a digital subscription product for weight loss and weight management; Core+ tier, a subscription for unlimited access to workshops; and Med+ subscription tier provides unlimited access to a clinician who can prescribe medications when clinically appropriate, including oral and injectable GLP 1s and hormone replacement therapy. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other weight management-relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1963 and is headquartered in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$28.33
Mean price target
2. Current target
$9.64
Latest analyst target
3. DCF / Fair value
$42.91
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$9.64
Low
$20.00
High
$35.00
Mean
$28.33

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-01-15 main Morgan Stanley Equal-Weight → Equal-Weight $35
2025-08-12 main Morgan Stanley Equal-Weight → Equal-Weight $41
2025-07-08 init LUCID CAPITAL MARKETS — → Buy $60
2024-08-02 main Guggenheim Buy → Buy $6
2024-08-02 main UBS Neutral → Neutral $1
2024-08-02 main Barclays Underweight → Underweight $1
2024-05-03 main DA Davidson Buy → Buy $6
2024-04-25 main UBS Neutral → Neutral $2
2024-03-18 reit Guggenheim Buy → Buy $12
2024-03-14 main DA Davidson Buy → Buy $13
2024-03-04 reit DA Davidson Buy → Buy $13
2024-03-01 main Barclays Underweight → Underweight $2
2024-02-29 main UBS Neutral → Neutral $3
2024-02-01 main Goldman Sachs Buy → Buy —
2024-01-23 main Goldman Sachs Buy → Buy $12
2023-12-20 init Guggenheim — → Buy $14
2023-10-09 reit DA Davidson Buy → Buy $13
2023-09-27 up Craig-Hallum Sell → Hold —
2023-09-25 reit DA Davidson Buy → Buy $13
2023-08-07 main DA Davidson Buy → Buy $13
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-01-02 BORNSTEIN JULIE D Director — 1,166 $0.00 $0
2026-01-02 SJOQVIST NIKOLAJ H Director — 1,166 $0.00 $0
2026-01-02 MASON MICHAEL B Director — 1,166 $0.00 $0
2026-01-02 HAWKS CARNEY Director — 1,166 $0.00 $0
2025-12-19 BORNSTEIN JULIE D Director — 1,219 $0.00 $0
2025-12-19 SJOQVIST NIKOLAJ H Director — 1,219 $0.00 $0
2025-12-19 MASON MICHAEL B Director — 1,219 $0.00 $0
2025-12-19 HAWKS CARNEY Director — 1,219 $0.00 $0
2025-11-19 HAWKS CARNEY Director — 29,057 $20.81 $643,464
2025-08-18 HAAG NICOLE Officer — 469 $30.86 $14,475
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Revenue
710.64
-9.58%
785.92
-11.65%
889.55
Operating Revenue
705.41
-9.21%
776.99
-5.56%
822.75
Cost Of Revenue
200.14
-20.84%
252.82
-29.82%
360.25
Reconciled Cost Of Revenue
200.14
-20.84%
252.82
-29.82%
360.25
Gross Profit
510.50
-4.24%
533.10
+0.72%
529.30
Operating Expense
464.06
+2.15%
454.29
-9.74%
503.34
Research And Development
42.39
+0.55%
42.16
-11.04%
47.39
Selling General And Administration
421.68
+2.32%
412.13
-9.61%
455.94
Selling And Marketing Expense
421.68
+2.32%
412.13
-9.61%
455.94
Total Expenses
664.20
-6.07%
707.11
-18.12%
863.59
Operating Income
46.43
-41.08%
78.81
+203.52%
25.97
Total Operating Income As Reported
18.89
+107.99%
-236.22
-1157.73%
22.33
EBITDA
1,222.54
+716.09%
-198.44
-365.53%
74.73
Normalized EBITDA
106.17
-8.94%
116.60
+48.79%
78.36
Reconciled Depreciation
67.68
+79.13%
37.78
-27.99%
52.47
EBIT
1,154.86
+588.89%
-236.22
-1161.14%
22.26
Total Unusual Items
1,116.37
+454.37%
-315.03
-8571.43%
-3.63
Total Unusual Items Excluding Goodwill
1,116.37
+454.37%
-315.03
-8571.43%
-3.63
Special Income Charges
1,116.37
+454.37%
-315.03
-8571.43%
-3.63
Restructuring And Mergern Acquisition
-1,143.92
0.00
0.00
Write Off
27.55
-91.26%
315.03
+8571.43%
3.63
Net Income
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Pretax Income
1,091.45
+416.20%
-345.18
-368.78%
-73.63
Net Non Operating Interest Income Expense
-63.41
+41.80%
-108.95
-13.62%
-95.89
Interest Expense Non Operating
63.41
-41.80%
108.95
+13.62%
95.89
Net Interest Income
-63.41
+41.80%
-108.95
-13.62%
-95.89
Interest Expense
63.41
-41.80%
108.95
+13.62%
95.89
Other Income Expense
1,108.43
+451.85%
-315.03
-8402.89%
-3.71
Other Non Operating Income Expenses
-7.94
-794300.00%
0.00
+101.39%
-0.07
Tax Provision
35.45
+6638.97%
0.53
-98.64%
38.62
Tax Rate For Calcs
0.00
-84.53%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
36.26
+154.80%
-66.16
-8571.43%
-0.76
Net Income Including Noncontrolling Interests
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Net Income From Continuing Operation Net Minority Interest
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Net Income From Continuing And Discontinued Operation
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Net Income Continuous Operations
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Normalized Income
-24.10
+75.10%
-96.82
+11.48%
-109.38
Net Income Common Stockholders
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Diluted EPS
7.58
+274.65%
-4.34
-197.26%
-1.46
Basic EPS
7.71
+277.65%
-4.34
-197.26%
-1.46
Basic Average Shares
9.99
-87.46%
79.65
+3.60%
76.89
Diluted Average Shares
9.99
-87.46%
79.65
+3.60%
76.89
Diluted NI Availto Com Stockholders
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Line Item Trend 2025-12-31 2024-12-31
Total Assets
946.76
+72.05%
550.28
Current Assets
213.60
+108.09%
102.65
Cash Cash Equivalents And Short Term Investments
160.28
+202.28%
53.02
Cash And Cash Equivalents
160.28
+202.28%
53.02
Receivables
16.38
+13.52%
14.43
Accounts Receivable
16.38
+13.52%
14.43
Gross Accounts Receivable
18.03
+2.47%
17.59
Allowance For Doubtful Accounts Receivable
-1.65
+47.85%
-3.17
Prepaid Assets
17.37
+4.37%
16.64
Restricted Cash
6.30
+109.72%
3.00
Other Current Assets
13.28
-14.61%
15.55
Total Non Current Assets
733.15
+63.79%
447.63
Net PPE
11.05
-80.90%
57.84
Gross PPE
25.82
-75.96%
107.41
Accumulated Depreciation
-14.77
+70.19%
-49.56
Properties
0.00
0.00
Other Properties
18.08
-72.85%
66.61
Leases
7.74
-81.03%
40.80
Goodwill And Other Intangible Assets
690.80
+94.40%
355.35
Goodwill
200.13
-16.47%
239.58
Other Intangible Assets
490.66
+323.86%
115.76
Non Current Deferred Assets
16.48
-1.22%
16.69
Non Current Deferred Taxes Assets
16.48
-1.22%
16.69
Other Non Current Assets
14.82
-16.49%
17.75
Total Liabilities Net Minority Interest
628.69
-62.23%
1,664.65
Current Liabilities
126.54
-27.00%
173.33
Payables And Accrued Expenses
96.71
-27.56%
133.51
Payables
49.59
-44.14%
88.79
Accounts Payable
9.21
-48.26%
17.80
Other Payable
34.38
-49.92%
68.65
Current Accrued Expenses
47.12
+5.36%
44.72
Total Tax Payable
6.01
+156.78%
2.34
Income Tax Payable
6.01
+156.78%
2.34
Current Debt And Capital Lease Obligation
1.26
-84.57%
8.17
Current Capital Lease Obligation
1.26
-84.57%
8.17
Current Deferred Liabilities
28.57
-9.76%
31.66
Current Deferred Revenue
28.57
-9.76%
31.66
Total Non Current Liabilities Net Minority Interest
502.15
-66.33%
1,491.32
Long Term Debt And Capital Lease Obligation
467.36
-68.31%
1,474.96
Long Term Debt
465.47
-67.46%
1,430.64
Long Term Capital Lease Obligation
1.89
-95.73%
44.32
Non Current Deferred Liabilities
34.02
+130.46%
14.76
Non Current Deferred Taxes Liabilities
34.02
+130.46%
14.76
Other Non Current Liabilities
0.77
-51.51%
1.59
Stockholders Equity
318.07
+128.54%
-1,114.37
Common Stock Equity
318.07
+128.54%
-1,114.37
Capital Stock
378.78
0.00
Common Stock
378.78
0.00
Share Issued
9.99
+0.05%
9.99
Ordinary Shares Number
9.99
+0.05%
9.99
Retained Earnings
-62.09
-103.21%
1,936.17
Gains Losses Not Affecting Retained Earnings
1.39
+105.38%
-25.83
Treasury Stock
0.00
-100.00%
3,024.71
Other Equity Adjustments
1.39
+105.38%
-25.83
Total Equity Gross Minority Interest
318.07
+128.54%
-1,114.37
Total Capitalization
783.54
+147.74%
316.27
Working Capital
87.07
+223.18%
-70.68
Invested Capital
783.54
+147.74%
316.27
Total Debt
468.62
-68.40%
1,483.13
Net Debt
305.19
-77.85%
1,377.62
Capital Lease Obligations
3.15
-93.99%
52.49
Net Tangible Assets
-372.73
+74.64%
-1,469.72
Tangible Book Value
-372.73
+74.64%
-1,469.72
Interest Payable
1.08
-90.43%
11.32
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Operating Cash Flow
-28.90
-71.60%
-16.84
-351.87%
6.69
Cash Flow From Continuing Operating Activities
-28.90
-71.60%
-16.84
-351.87%
6.69
Net Income From Continuing Operations
1,056.01
+405.47%
-345.70
-207.96%
-112.25
Depreciation Amortization Depletion
67.68
+79.13%
37.78
-27.99%
52.47
Depreciation And Amortization
67.68
+79.13%
37.78
-27.99%
52.47
Other Non Cash Items
-1,174.82
-23512.08%
5.02
+0.00%
5.02
Stock Based Compensation
4.64
-40.29%
7.76
-48.87%
15.19
Provisionand Write Offof Assets
15.22
+162.26%
-24.44
-185.84%
28.48
Asset Impairment Charge
27.68
-91.23%
315.51
+6549.40%
4.75
Operating Gains Losses
8.00
+451.58%
-2.28
-965.40%
0.26
Net Foreign Currency Exchange Gain Loss
8.00
+451.58%
-2.28
-965.40%
0.26
Change In Working Capital
-6.24
+45.85%
-11.52
-188.64%
12.99
Change In Receivables
0.68
-57.47%
1.60
-90.66%
17.11
Changes In Account Receivables
0.68
-57.47%
1.60
-90.66%
17.11
Change In Inventory
0.01
-94.51%
0.09
-99.35%
14.02
Change In Prepaid Assets
4.89
-73.88%
18.70
+552.53%
-4.13
Change In Payables And Accrued Expense
-3.93
+74.64%
-15.51
-32.77%
-11.68
Change In Accrued Expense
6.23
+141.56%
-15.00
-29.02%
-11.62
Change In Payable
-10.17
-1901.18%
-0.51
-840.74%
-0.05
Change In Account Payable
-10.17
-1901.18%
-0.51
-840.74%
-0.05
Change In Other Working Capital
-7.88
+51.99%
-16.40
-605.55%
-2.33
Investing Cash Flow
-19.50
-18.81%
-16.41
+78.02%
-74.70
Cash Flow From Continuing Investing Activities
-19.50
-18.81%
-16.41
+78.02%
-74.70
Capital Expenditure
-17.48
-6.53%
-16.41
+54.79%
-36.30
Capital Expenditure Reported
-17.48
-6.53%
-16.41
+54.79%
-36.30
Net Business Purchase And Sale
-2.02
0.00
+100.00%
-38.36
Purchase Of Business
-2.02
0.00
+100.00%
-38.36
Net Other Investing Changes
—
-0.01
+84.85%
-0.03
Financing Cash Flow
153.90
+987.38%
-17.34
-530.88%
-2.75
Cash Flow From Continuing Financing Activities
153.90
+987.38%
-17.34
-530.88%
-2.75
Net Issuance Payments Of Debt
171.34
0.00
0.00
Issuance Of Debt
171.34
0.00
0.00
Long Term Debt Issuance
171.34
0.00
0.00
Net Long Term Debt Issuance
171.34
0.00
0.00
Proceeds From Stock Option Exercised
0.00
0.00
-100.00%
0.72
Net Other Financing Charges
—
-17.34
-400.23%
-3.47
Changes In Cash
105.50
+308.50%
-50.60
+28.49%
-70.76
Effect Of Exchange Rate Changes
4.56
+302.76%
-2.25
-224.96%
1.80
Beginning Cash Position
230.14
+110.43%
109.37
-38.67%
178.33
End Cash Position
340.20
+501.91%
56.52
-48.32%
109.37
Free Cash Flow
-46.38
-39.48%
-33.25
-12.27%
-29.61
Taxes Refund Paid
-27.07
-2759.33%
1.02
+582.46%
-0.21
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category